Enfusion Inc
NYSE:ENFN

Watchlist Manager
Enfusion Inc Logo
Enfusion Inc
NYSE:ENFN
Watchlist
Price: 10.1 USD
Market Cap: 1.3B USD
Have any thoughts about
Enfusion Inc?
Write Note

Enfusion Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Enfusion Inc
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Enfusion Inc
NYSE:ENFN
Cash & Cash Equivalents
$35.6m
CAGR 3-Years
37%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Salesforce Inc
NYSE:CRM
Cash & Cash Equivalents
$7.7B
CAGR 3-Years
7%
CAGR 5-Years
17%
CAGR 10-Years
26%
Palantir Technologies Inc
NYSE:PLTR
Cash & Cash Equivalents
$831m
CAGR 3-Years
-26%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Applovin Corp
NASDAQ:APP
Cash & Cash Equivalents
$502.2m
CAGR 3-Years
17%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Intuit Inc
NASDAQ:INTU
Cash & Cash Equivalents
$3.6B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
16%
Adobe Inc
NASDAQ:ADBE
Cash & Cash Equivalents
$7.7B
CAGR 3-Years
18%
CAGR 5-Years
28%
CAGR 10-Years
24%
No Stocks Found

Enfusion Inc
Glance View

Market Cap
1.3B USD
Industry
Technology

Enfusion, Inc. engages in the development of cloud-native multi-tenant software for alternative and institutional investment managers. The company is headquartered in Chicago, Illinois. The company went IPO on 2021-10-21. The products and services that comprise its solution are designed to enable investment managers to take investment decisions in real time. The Company’s solution, comprised of mission critical systems integrated with a suite of technology-powered, managed services, serves the full investment lifecycle, drives insights into and control over the business activities of the investment manager and investment operations. Its solution’s end-to-end functionality includes Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System and Enfusion Analytics System. PMS able to comprehensively construct and re-balance investment portfolios, this system generates a real-time investment book of record. PMS module offers portfolio managers, traders, compliance teams and analysts the ability to electronically communicate trade orders.

ENFN Intrinsic Value
9.38 USD
Overvaluation 7%
Intrinsic Value
Price

See Also

What is Enfusion Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
35.6m USD

Based on the financial report for Dec 31, 2023, Enfusion Inc's Cash & Cash Equivalents amounts to 35.6m USD.

What is Enfusion Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
37%

Over the last year, the Cash & Cash Equivalents growth was -43%. The average annual Cash & Cash Equivalents growth rates for Enfusion Inc have been 37% over the past three years .

Back to Top